肺CCR2+CD4+ T细胞具有免疫调节作用并减轻肺纤维化发展
该研究探讨了CCR2+CD4+ T细胞在实验性肺纤维化及特发性肺纤维化等患者中的作用。通过流式细胞术、mRNA分析、体外实验和过继转移实验,发现CCR2+CD4+ T细胞频率在纤维化中增加,具有免疫抑制功能,过继转移可减轻纤维化。患者支气管肺泡灌洗液中CCR2+CD4+ T细胞中Foxp3+CD25+细胞比例高于CCR2-CD4+ T细胞。
要点
- 肺CCR2+CD4+ T细胞具有免疫抑制性,可减轻肺炎症和纤维化。
- 完全阻断CCR2依赖性信号可能消除具有保护作用的细胞群。
- 需深入理解纤维化肺病中免疫细胞亚群的功能。
核心结论
- 肺CCR2+CD4+ T细胞具有免疫抑制性,可减轻肺炎症和纤维化。
- 完全阻断CCR2依赖性信号的治疗策略将同时消除对纤维化肺病具有保护作用的细胞群。
研究设计与样本
- 研究分析了实验性肺纤维化模型及特发性肺纤维化和其他纤维化患者中的肺CCR2+CD4+ T细胞。
- 采用流式细胞术和mRNA谱分析,随后进行计算机通路分析、体外实验和过继转移实验。
主要发现
- 实验性纤维化中CCR2+CD4+ T细胞频率增加,特别是CD62L-CD44+效应记忆T细胞表型,呈现独特的趋化因子受体谱。
- 从纤维化肺分离的CCR2+CD4+ T细胞的mRNA谱提示免疫调节功能,体外抑制试验证实。
- 过继转移CCR2+CD4+ T细胞减轻纤维化发展。
- 肺纤维化患者支气管肺泡灌洗液中CCR2+CD4+ T细胞中Foxp3+CD25+细胞比例高于CCR2-CD4+ T细胞。
临床怎么用
- 针对CCR2依赖性信号的治疗策略需考虑保留具有保护作用的CCR2+CD4+ T细胞亚群。
- 在纤维化肺病中应详细评估免疫细胞亚群的功能,而非全面阻断CCR2通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Animal models have suggested that CCR2-dependent signalling contributes to the pathogenesis of pulmonary fibrosis, but global blockade of CCL2 failed to improve the clinical course of patients with lung fibrosis. However, as levels of CCR2+CD4+ T cells in paediatric lung fibrosis had previously been found to be increased, correlating with clinical symptoms, we hypothesised that distinct CCR2+ cell populations might either increase or decrease disease pathogenesis depending on their subtype. OBJECTIVE: To investigate the role of CCR2+CD4+ T cells in experimental lung fibrosis and in patients with idiopathic pulmonary fibrosis and other fibrosis. METHODS: Pulmonary CCR2+CD4+ T cells were analysed using flow cytometry and mRNA profiling, followed by in silico pathway analysis, in vitro assays and adoptive transfer experiments. RESULTS: Frequencies of CCR2+CD4+ T cells were increased in experimental fibrosis-specifically the CD62L-CD44+ effector memory T cell phenotype, displaying a distinct chemokine receptor profile. mRNA profiling of isolated CCR2+CD4+ T cells from fibrotic lungs suggested immune regulatory functions, a finding that was confirmed in vitro using suppressor assays. Importantly, adoptive transfer of CCR2+CD4+ T cells attenuated fibrosis development. The results were partly corroborated in patients with lung fibrosis, by showing higher percentages of Foxp3+ CD25+ cells within bronchoalveolar lavage fluid CCR2+CD4+ T cells as compared with CCR2-CD4+ T cells. CONCLUSION: Pulmonary CCR2+CD4+ T cells are immunosuppressive, and could attenuate lung inflammation and fibrosis. Therapeutic strategies completely abrogating CCR2-dependent signalling will therefore also eliminate cell populations with protective roles in fibrotic lung disease. This emphasises the need for a detailed understanding of the functions of immune cell subsets in fibrotic lung disease.
引用
- Milger K, Yu Y, Brudy E, et al. Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development. Thorax. 2017. PMID: 28780502. doi:10.1136/thoraxjnl-2016-208423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。